In agreement with this, previous reports showed a lack of association of EPC quantification with PFTs and smoking status in IPF patients [12], as well as with the duration of RA disease, CRP and ESR levels, ACPA and RF status, or therapies in RA patients [7,8]. The gene discussed is PRTN3; the disease is rheumatoid arthritis.